Literature DB >> 30540561

MECHANISMS OF ENDOCRINOLOGY: Mechanisms of disease: the endocrinology of obstructive sleep apnoea.

Aikaterini Lavrentaki1, Asad Ali2, Brendan G Cooper3,4, Abd A Tahrani1,5,6.   

Abstract

Obstructive sleep apnoea (OSA) is a common disorder that is associated with serious comorbidities with a negative impact on quality of life, life expectancy and health costs. As OSA is related to obesity and is associated with sleep disruption, increased inflammation and oxidative stress, it is not surprising that OSA has an impact on the secretion of multiple hormones and is implicated in the development of many endocrine conditions. On the other hand, many endocrine conditions that can affect obesity and/or upper airways anatomy and stability have been implicated in the development or worsening of OSA. This bidirectional relationship between OSA and the endocrine system has been increasingly recognised in experimental and epidemiological studies and there are an increasing number of studies examining the effects of OSA treatment on endocrine conditions and vice versa. In this review article, we will critically appraise and describe the impact of OSA on the endocrine system including obesity, dysglycaemia, the pituitary, the thyroid, the adrenals, the reproductive system and the bones. In each section, we will assess whether a bidirectional relationship exists, and we will describe the potential underlying mechanisms. We have focused more on recent studies and randomised controlled trials where available and attempted to provide the information within clinical context and relevance.

Entities:  

Year:  2019        PMID: 30540561     DOI: 10.1530/EJE-18-0411

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

Review 1.  Metformin: Mechanisms in Human Obesity and Weight Loss.

Authors:  Armen Yerevanian; Alexander A Soukas
Journal:  Curr Obes Rep       Date:  2019-06

2.  The impact of thyroidectomy on obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Razan Masarwy; Liyona Kampel; Omer J Ungar; Anton Warshavsky; Gilad Horowitz; Eyal Rosenzweig; Riva Tauman; Nidal Muhanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-20       Impact factor: 2.503

Review 3.  The Role of Aldosterone in OSA and OSA-Related Hypertension.

Authors:  Yi Wang; Chuan Xiang Li; Ying Ni Lin; Li Yue Zhang; Shi Qi Li; Liu Zhang; Ya Ru Yan; Fang Ying Lu; Ning Li; Qing Yun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-12       Impact factor: 5.555

4.  Obstructive sleep apnoea and 12-month weight loss in adults with class 3 obesity attending a multidisciplinary weight management program.

Authors:  Sophie Kobuch; Fiona Tsang; Ritesh Chimoriya; Daniel Gossayn; Sarah O'Brien; Javeria Jamal; Leon Laks; Abd Tahrani; Nic Kormas; Milan K Piya
Journal:  BMC Endocr Disord       Date:  2021-11-14       Impact factor: 2.763

Review 5.  The links between sleep duration, obesity and type 2 diabetes mellitus.

Authors:  Christina Antza; Georgios Kostopoulos; Samiul Mostafa; Krishnarajah Nirantharakumar; Abd Tahrani
Journal:  J Endocrinol       Date:  2021-12-13       Impact factor: 4.286

6.  Association Between Poor Sleep Quality and Glycemic Control in Adult Patients with Diabetes Referred to Endocrinology Clinic of Guilan: A Cross-sectional Study.

Authors:  Mojtaba Mehrdad; Mehrnaz Azarian; Amir Sharafkhaneh; Ali Alavi; Roghayeh Zare; Afagh Hassanzadeh Rad; Setila Dalili
Journal:  Int J Endocrinol Metab       Date:  2021-12-05

7.  Contribution of Obstructive Sleep Apnoea to Cognitive Functioning of Males With Coronary Artery Disease: A Relationship With Endocrine and Inflammatory Biomarkers.

Authors:  Nijole Kazukauskiene; Naomi A Fineberg; Aurelija Podlipskyte; Adomas Bunevicius; Nicolás Francisco Narvaez Linares; Marilou Poitras; Hélène Plamondon; Aiste Pranckeviciene; Julija Gecaite-Stonciene; Narseta Mickuviene; Giedrius Varoneckas; Julius Burkauskas
Journal:  Front Neurosci       Date:  2022-07-18       Impact factor: 5.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.